# Projet Lucine

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/projet-lucine

- Industry: Medical Devices & Equipment
- Headquarters: Bordeaux, France
- Website: www.lucine.fr
- Total disclosed funding: $6.7M
- Latest round: Seed (Jan 22, 2021)
- Investors on record: 5

## About

Projet Lucine is a healthcare technology company focused on enhancing patient outcomes through innovative digital health solutions that facilitate efficient health management and personalized care.Founded in 2017 and headquartered in Bordeaux, France, Projet Lucine specializes in developing healthcare technology solutions. The company has pivoted towards enhancing its digital platform for better patient engagement. The founders are LJ Liu and Maryne Cotty-Eslous, who also serves as the CEO. In January 2021, Projet Lucine raised EUR 5.5 million in Seed funding, with Bpifrance Investissement leading the round, joined by investors such as Aquiti Gestion and BNP Paribas Développement. The total amount raised to date is EUR 5.5 million, and the company is valued at EUR 14.56 million.Lucine.care offers healthcare solutions designed to improve patient outcomes and streamline health management. Their digital platform enables personalized health tracking, allowing users to monitor health metrics and engage with healthcare providers effectively. Their target market includes healthcare facilities, such as hospitals and clinics, across North America and selected countries in Europe and Asia, addressing challenges in chronic disease management and preventative care.In the most recent year, 2020, Projet Lucine generated revenue of EUR 1,407,826.50 with an EBITDA of EUR 569,842. The company utilizes a subscription-based model, providing services to healthcare providers and individual consumers to enhance patient engagement and service delivery.Following the EUR 5.5 million Seed funding round in January 2021, Projet Lucine aims to expand its product offerings and enter new markets. The company plans to launch additional features on its platform designed for enhanced health monitoring and support. Targeting expansion into North American and Asian markets by 2023, the funding will primarily be utilized to enhance product development and market outreach initiatives.

## Funding rounds

- Seed, Jan 22, 2021, $6.7M — Kurma Partners, IRDI SORIDEC Gestion, Bpifrance Investissement, Aquiti Gestion, BNP Paribas Developpement

## Investors

- Kurma Partners (https://capitalatlas.ai/funds/kurma-partners) — Seed
- IRDI SORIDEC Gestion — Seed
- Bpifrance Investissement (https://capitalatlas.ai/funds/bpifrance-investissement) — Seed
- Aquiti Gestion (https://capitalatlas.ai/funds/aquiti-gestion) — Seed
- BNP Paribas Developpement (https://capitalatlas.ai/funds/bnp-paribas-developpement) — Seed